NCT07368101

Brief Summary

The goal of this clinical trial is to compare the outcome of double burr hole versus single burr hole in patients of chronic subdural hematoma undergoing subdural drain evacuation. The main questions it aims to answers are 1\. Which one of the surgical method i.e single burr hole or double burr hole is clinically superior with better post operative prognosis for the drainage of chronic subdural hematoma. 2 Compare the post operative complications in both the techniques in term of wound infection hospital stay duration , recurrence and mortality. participants will be divided in two groups one group will be treated with single burr hole technique second group will be treated with double burr hole technique. After procedure, patients will be followed-up in hospital until discharge and total hospital stay will be noted. Patients will be followed-up further in OPD . During follow-up, patients will be evaluated for wound infection, recurrence and mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

5 months

First QC Date

January 12, 2026

Last Update Submit

January 20, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Recurrence Of Chronic Subdural Hematoma

    recurrence rate of chronic subdural hematoma evaluated if volume of sdh \>15ml or significant mass effect on CT brain within 3 months post operatively

    From date of surgery until radiologically confirmed recurrence (defined as subdural hematoma volume >15 mL or significant mass effect on CT brain) requiring repeat intervention, assessed up to 3 months postoperatively

  • quantity of hematoma evacuated

    Intraoperatively evacuated hematoma quantity measured in millilitres and also includes the quantity obtained in subdural drain till 72 hours postoperatively

    Measured intraoperatively at the time of surgery and cumulatively measured postoperatively from surgery until removal of the subdural drain, assessed up to 72 hours postoperatively.

Study Arms (2)

Double burr Hole Arm

EXPERIMENTAL

this arm includes patient who receive double burr hole craniotomy surgical procedure for drainage of chronic subdural hematoma

Procedure: Double Burr hole Craniotomy

Single Burr Hole Arm

EXPERIMENTAL

this arm includes patient who receive single burr hole craniotomy surgical procedure for drainage of chronic subdural hematoma

Procedure: Single Burr hole Craniotomy

Interventions

Single Burr hole made at the point of highest collection of hematoma in subdural space in brain.

Single Burr Hole Arm

Two burr hole made in skull each at parietal eminence and around superior temporal line to drain chronic subdural hematoma

Double burr Hole Arm

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 20-70 years both genders diagnosed with subdural hematoma

You may not qualify if:

  • Patients in shock (BP≤100/60 mmHg) or history of seizures
  • Patients with bleeding disorder (PT\>15 sec) or intake of anti-coagulants
  • Patients undergoing or already had ventriculoperitoneal shunt
  • Patients with epilepsy, or obsessive compulsive decoder
  • Patients with already operated for subdural hematoma
  • Patients with post-cerebrospinal fluid diversion subdural hematoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Services Institute of Medical Sciences / Services Hospital

Lahore, Punjab Province, 54770, Pakistan

Location

MeSH Terms

Conditions

Hematoma, Subdural, Chronic

Condition Hierarchy (Ancestors)

Hematoma, SubduralIntracranial Hemorrhage, TraumaticIntracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemVascular DiseasesCardiovascular DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHematomaHemorrhageWounds and Injuries

Study Officials

  • Muhammad Hassan Tabish, MBBS

    Services Hospital / Services Institute of Medical Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Muhammad Hassan Tabish , MBBS, Neurosurgery Resident / Principal Investigator

Study Record Dates

First Submitted

January 12, 2026

First Posted

January 26, 2026

Study Start

October 4, 2024

Primary Completion

March 7, 2025

Study Completion

May 9, 2025

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations